International Biotechnology (LON:IBT) Stock Crosses Above 200 Day Moving Average of $657.12

International Biotechnology (LON:IBTGet Free Report)’s share price crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 657.12 ($8.68) and traded as high as GBX 696.40 ($9.20). International Biotechnology shares last traded at GBX 694 ($9.17), with a volume of 56,388 shares.

International Biotechnology Price Performance

The company has a debt-to-equity ratio of 9.66, a quick ratio of 0.32 and a current ratio of 0.46. The company has a fifty day moving average price of GBX 685.39 and a two-hundred day moving average price of GBX 657.12. The company has a market cap of £256.50 million, a P/E ratio of 1,445.83 and a beta of 0.21.

International Biotechnology Increases Dividend

The company also recently announced a dividend, which was paid on Friday, August 23rd. Investors of record on Thursday, July 25th were paid a GBX 14.50 ($0.19) dividend. The ex-dividend date of this dividend was Thursday, July 25th. This is a boost from International Biotechnology’s previous dividend of $13.90. This represents a dividend yield of 2.28%. International Biotechnology’s dividend payout ratio (DPR) is currently 6,041.67%.

Insider Transactions at International Biotechnology

In other International Biotechnology news, insider Gillian Elcock purchased 1,407 shares of the stock in a transaction on Wednesday, July 24th. The shares were purchased at an average price of GBX 709 ($9.37) per share, with a total value of £9,975.63 ($13,177.85). 4.18% of the stock is owned by company insiders.

About International Biotechnology

(Get Free Report)

International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments.

Recommended Stories

Receive News & Ratings for International Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.